Novavax plans for second round of layoffs, cost cuts as weak vaccine uptake pummels manufacturers

Novavax plans for second round of layoffs, cost cuts as weak vaccine uptake pummels manufacturers

Upworthy

Published

Six months after announcing a first wave of cost cuts, Novavax is instituting another round, looking to shave off a further $300 million in spending with more layoffs on the way. The drug developer, which is still sprinting to catch up to Pfizer and Moderna in the COVID-19 vaccine race, announced…

#pfizer #fierce #sga #cfojimkelly #johnjacobs #jacobs #moderna

Full Article